Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00904878 · ClinicalTrials.gov registry record
A Multicenter National Prospective Study of Pregnancy and Neonatal Outcomes in Women With Inflammatory Bowel Disease
A clinical trial of Inflammatory Bowel Disease, sponsored by University of California, San Francisco.
- Recruiting
- Registry status
- 1,500
- Enrollment target
- 2
- Study locations
NCT00904878 is a study of Inflammatory Bowel Disease that is actively recruiting participants, run by University of California, San Francisco. The registered enrollment target is 1,500 participants, above the 350-participant average among 28 other Inflammatory Bowel Disease trials with a reported enrollment target (329% higher). The trial reports 2 study locations across 1 state.
The verdict
NCT00904878, a study of Inflammatory Bowel Disease, is actively recruiting participants, sponsored by University of California, San Francisco.
- RECRUITING
- Registry status
- 1,500 participants
- Enrollment target
- 2
- Study locations
Study Summary
A Multicenter National Prospective Study of Pregnancy and Neonatal Outcomes in Women with Inflammatory Bowel Disease study is being conducted at the University of California San Francisco and 30 other sites around the United States who are part of the CCFA Clinical Alliance. The aim of this study is to determine the effect of medication use and disease activity on the outcome of pregnancy among women with IBD up to 18 years from birth.
Conditions Studied
Study Locations (2)
California
- Please Contact Jessica Lim For Further Information Regarding Other Sites' Locations - San Francisco
- University of California San Francisco - San Francisco
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,500 participants |
| Start Date | 2007-08 |
| Est. Completion | 2028-06 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00904878
The ClinicalTrials.gov registry entry for NCT00904878 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 1,500 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 350-participant average among 28 other Inflammatory Bowel Disease trials with a reported enrollment target (329% higher). The listed sponsor is University of California, San Francisco, which has 1,713 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Inflammatory Bowel Disease appearing as the primary indexed condition, and to 0 interventions.
NCT00904878 reports 2 study locations spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT00904878 about?
NCT00904878 is a clinical study titled "A Multicenter National Prospective Study of Pregnancy and Neonatal Outcomes in Women With Inflammatory Bowel Disease". A Multicenter National Prospective Study of Pregnancy and Neonatal Outcomes in Women with Inflammatory Bowel Disease study is being conducted at the University of California San Francisco and 30 other sites around the United States who are part of the CCFA Clinical Alliance. The aim of this study is...
What is the current status of trial NCT00904878?
This trial is currently recruiting. The enrollment target is 1,500 participants. The study started on 2007-08. Estimated completion is 2028-06.
What conditions does trial NCT00904878 study?
This clinical trial studies the following conditions: Inflammatory Bowel Disease.
Who is sponsoring clinical trial NCT00904878?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00904878 being conducted?
This trial has 2 study locations across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Inflammatory Bowel Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Impact of Morning Light Therapy in IBD
RECRUITING · NA
-
Nivolumab in Treating Patients With Autoimmune Disorders and Advanced, Metastatic, or Unresectable Cancer
RECRUITING · Phase 1
-
Testing of an Educational Tool for Patients With Melanoma and Pre-Existing Autoimmune Disease Who Are Candidates for Immune Checkpoint Inhibitors
RECRUITING
-
High Dose Interval Vitamin D Supplementation in Patients With Inflammatory Bowel Disease Receiving Biologic Therapy
RECRUITING
-
Skeletal Health and Bone Marrow Composition in Newly Diagnosed Adolescents With Crohn Disease
RECRUITING
-
Effect of Mediterranean Diet in Inflammatory Bowel Disease
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.